Centene Corporation
CNC Healthcare Healthcare Plans
Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024.
- Revenue
- +1.93%
- EPS
- +99.0%
- Free cash flow
- −437.4%
- Total debt
- −11.6%
Quarter to September 2026, against a year earlier
Follow CNC
Alert me
Centene Corporation (CNC) P/E ratio
As of 6 November 2026, Centene Corporation (CNC) trades at a P/E ratio of 23.5×. Over the past ten years it has ranged from 0.0× (September 2026) to 67.2× (December 2021); the current reading is higher than 67% of that period. That is in line with the Healthcare Plans industry median of 22.5× and in line with the Healthcare sector median of 24.5×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 9.7× | (38.00%) |
| FY2023 | 15.6× | (59.35%) |
| FY2022 | 38.3× | 7.47% |
| FY2021 | 35.7× | 85.40% |
| FY2020 | 19.2× | (2.38%) |
| FY2019 | 19.7× | (18.98%) |
| FY2018 | 24.3× | 13.80% |
| FY2017 | 21.4× | 18.38% |
| FY2016 | 18.1× | (18.25%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 20.9× | — |
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| MOH Molina Healthcare, Inc compare | n/m |
| CVS CVS Health Corporation compare | 9.6× |
| OSCR Oscar Health, Inc. compare | 11.0× |
| CI Cigna Group compare | 12.9× |
| ELV Elevance Health, Inc. compare | 18.2× |
| UNH UnitedHealth Group Incorporated compare | 22.5× |
| CNC Centene Corporation | 23.5× |
| PGNY Progyny, Inc. compare | 30.1× |
| HUM Humana Inc. compare | 41.9× |
| Healthcare Plans industry median | 22.5× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on CNC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement